Tag search results
Tags let us describe our content with keywords, making it easier to find what you're most interested in. Use the search box to look for tags, or explore our coverage with the lists below.
Two of the owners of the company that makes OxyContin acknowledged to a congressional committee on Thursday that the powerful prescription painkiller has played a role in the national opioid crisis but stopped short of apologizing or admitting wrongdoing.
A bipartisan congressional investigation released Wednesday found that key players in the nation’s opioid industry have spent $65 million since 1997 funding nonprofits that advocate treating pain with medications, a strategy intended to boost the sale of prescription painkillers.
When it filed for bankruptcy last year, Purdue Pharma agreed to an innovative plan: It would make $200 million available immediately to help those those harmed by its signature painkiller, OxyContin, and ease the effects of the opioid crisis. More than a year later, with the crisis worsening, not a penny has been spent.
Purdue Pharma pleaded guilty Tuesday to three criminal charges, formally admitting its role in an opioid epidemic that has contributed to hundreds of thousands of deaths over the past two decades.
A federal bankruptcy judge has agreed to give individuals an additional 30 days to make claims against OxyContin maker Purdue Pharma because of potential disruptions caused by the coronavirus pandemic.
OxyContin maker Purdue Pharma launched an ad campaign Monday to tell people harmed by their powerful prescription opioid where they can file claims against the company.
Members of the family that own OxyContin maker Purdue Pharma say they will push to reverse Tufts University’s decision to strip their name from campus facilities and programs
State attorneys general with pending lawsuits against OxyContin maker Purdue Pharma and its owners will ask a federal bankruptcy judge Wednesday to give them more time to continue negotiating.
A judge is pushing for a settlement of more than 2,600 lawsuits facing OxyContin maker Purdue Pharma with a decision Friday to pause litigation against the company and members of the wealthy Sackler family that owns the company.
Lawmakers asked the city’s legal team last year to explore litigation against the makers of OxyContin and other prescription painkillers, cited as the major source of the country’s opioid crisis. The contract with a Seattle law firm to pursue legal action follows a request by the City Council for city attorneys to take another look at joining in the wake of one of the manufacturers announcing a multibillion dollar settlement.
A judge has cleared the way for OxyContin maker Purdue Pharma to stay in business while it pursues bankruptcy protection and settlement of more than 2,600 lawsuits filed over the opioid crisis. Purdue lawyers secured permission Tuesday for the company to maintain business as usual. That includes paying employees and vendors, supplying pills to distributors, and keeping current on taxes and insurance.
OxyContin maker Purdue Pharma says its bankruptcy filing is not a way to seek refuge but rather an effort to resolve claims against it.
The family that owns OxyContin maker Purdue Pharma used Swiss and other hidden accounts to transfer $1 billion to themselves, New York’s attorney general contends in court papers filed Friday.
OxyContin maker Purdue Pharma says it wants a nationwide settlement over its role in the opioids crisis, but it’s proving difficult to reach a deal
State attorneys general and lawyers representing local governments say they are in active settlement negotiations amid a report that OxyContin maker Purdue Pharma has offered to settle for $10 billion to $12 billion.
Dr. Raeford Brown was uniquely positioned to help the U.S. government answer a critical question: Is a new version of the painkiller OxyContin helping fight the national opioid epidemic?
California on Monday became the latest state to sue the pharmaceutical company behind the painkiller OxyContin, alleging it falsely promoted the drug as not addictive even as it emerged as one of the most widely abused in the U.S.
The maker of OxyContin and the company’s controlling family agreed Tuesday to pay a groundbreaking $270 million to Oklahoma to settle allegations they helped create the nation’s deadly opioid crisis with their aggressive marketing of the powerful painkiller.
OxyContin maker Purdue Pharma is asking a Massachusetts court to throw out a lawsuit filed by the state’s attorney general that accuses the company, its owners and top executives of deceiving patients and doctors about the risks of opioids.
The state of Montana is seeking a preliminary injunction to prevent the maker of the powerful painkiller OxyContin from marketing opioids to Montana prescribers, seeking to put the force of a court order behind Purdue Pharma’s recent promise to end such marketing nationwide.